Page 2448

(f) Members of the drug use review committee will be nominated by the department and appointed by the commissioner to a three-year term, except that the term length of initial appointments to the committee may be varied by the commissioner to effect staggered expiration dates. A member may not serve more than two consecutive terms. If an individual has not served for three consecutive years, that individual may be reappointed to the committee, not to exceed two consecutive terms. The drug use review committee shall consist of at least

(1) one-third, but no more than 51 percent, licensed and actively practicing physicians;

(2) one-third licensed and actively practicing pharmacists;

(3) an employee of the department; and

(4) at the discretion of the commissioner, other health care providers. (g) For purposes of this section, “pharmacist” includes a person who dispenses prescription drugs for outpatient use. (h) For purposes of this section, 42 C.F.R. 456.703, 456.705, 456.711, 456.712, and 456.716 are adopted by reference in 7 AAC 160.900. (Eff. 2/1/2010, Register 193) Statutory Authority: Authority: AS 47.05.010 AS 47.07.030 AS 47.07.040 7 AAC 120.130. Interim and final prior authorization medication lists and limitations on prescribed drugs. (a) Except as provided in (c) of this section, a prescribing or dispensing provider must obtain prior authorization from the department for a medically accepted indication before dispensing a drug

(1) identified on the Alaska Medicaid Prior-authorized Medications list, adopted by reference in 7 AAC 160.900; or

(2) not identified on the Alaska Medicaid Prior-authorized Medications list, if

(A) the drug is a new drug that the United States Food and Drug Administration approved after the publication date of that list; or

(B) the department, in consultation with the drug use review committee